Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients. - Université de Lorraine Access content directly
Journal Articles Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology Year : 2002

Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.

Abstract

As conflicting results have been observed by some authors in liver recipients, the aim of the study was to evaluate lamivudine therapy in 3 groups of patients with chronic hepatitis B: non-transplanted patients, liver and kidney recipients.
No file

Dates and versions

hal-02014614 , version 1 (11-02-2019)

Identifiers

  • HAL Id : hal-02014614 , version 1
  • PUBMED : 11938042

Cite

Evelyne Schvoerer, Imed Kabissa, Emmanuelle Cotto, Anne-Christine Jouvencel, Charles Balabaud, et al.. Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, 2002, 26 (1), pp.62-6. ⟨hal-02014614⟩

Collections

UNIV-LORRAINE
28 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More